This finding could have a great impact on the study of paediatric tumours, as it could already constitute one of the factors that produces their growth.
List view / Grid view
In a Phase I clinical trial, heart failure patients treated with patches made from their muscle cells showed improved exercise capacity and heart function after one year. Stem cell patch-based therapy may be a viable heart failure therapy and should be validated in larger clinical trials, researchers conclude.
31 October 2016 | By Niamh Louise Marriott, Digital Content Producer
"In our preclinical assessments of stem cell-derived dopamine neurons we noticed that the outcome in animal models varied dramatically, even though...